期刊文献+

阿克拉霉素诱导原代白血病细胞凋亡的实验研究 被引量:1

Apoptosis of Primary Acute Leukemic Cells Induced by Aclacinomycin in Vitro
下载PDF
导出
摘要 目的 研究阿克拉霉素 (ACM)体外抑制原代急性白血病 (AL)细胞的生长及其机理。方法 MTT法研究 37例初发AL细胞的生长抑制。DNA片段原位末端标记 (TUNEL)法检测 2 0例AL细胞的凋亡率。结果 ACM体外能明显抑制原代AL细胞的生长 ;细胞形态学、DNA琼脂糖凝胶电泳均证实ACM能诱导原代AL细胞凋亡 ;与空白对照相比 ,ACM在体外与原代AL细胞共同培养 15小时后 ,TUNEL阳性细胞率明显增高 ,差异有统计学意义 (30 89± 15 90 %对 14 85± 15 90 %;P <0 0 1) ;且TUNEL阳性细胞率与MTT抑制率呈正相关 (r =0 32 6 ,P =0 0 4)。结论 诱导细胞凋亡是ACM抑制原代AL细胞增殖的重要机制之一。 Objective To elucidate the proliferation inhibition induced by aclacinomycin(ACM) in vitro and its mechanism.Methods The proliferation inhibition of leukemic cells of 37 patients with AL was examined by MTT assay.The apoptosis of leukemic cells of 20 patients with AL was analyzed with the method of TUNEL (terminal deoxyribonucleotidyl transferase-mediated dUTP-biotin nick end labeling).Results Cytostatic effect induced by ACM was significant;The apoptosis of leukemic cells induced by ACM was confirmed from the change of cell morphology and DNA agar glucose electroresis;when AL cells were cultured with ACM for 15 hours,the rate of TUNEL-positive AL cells was significantly higher than that in the control group(30.89±15.90% vs 14.85±15.90%,P<0.01);And it was correlated colsely with the TUNEL-positive rate and MTT proliferation inhibition of AL cells induced by ACM(r=0.326,P=0.04).Conclusions These findings suggested that ACM can induce apoptosis of primary AL cells,that may be one of the mechenisms of ACM-induced proliferation inhibition of leukemic cells.
作者 孟小莉
出处 《河南肿瘤学杂志》 2003年第4期237-239,共3页 Henan Journal of Oncology
关键词 阿克拉霉素 诱导 原代白血病 细胞凋亡 实验研究 MTT法 TUNEL法 细胞增殖 aclacinomycin leukemic cells primary acute apoptosis
  • 相关文献

参考文献7

  • 1万景华,殷建林.急性非淋巴细胞白血病综合药敏试验的研究[J].中华血液学杂志,1989,10(5):247-249. 被引量:10
  • 2陈敏,冯文莉,黄宗干.柔红霉素对HL-60细胞的促凋亡作用及其与ROS、CER、NF-κB关系的实验研究[J].中华血液学杂志,2002,23(9):471-473. 被引量:10
  • 3Saito, K, Nakamura, Y, Aoyagi, et al. Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor(CAG rgimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia(AML) and previously untreated elderly patients with AML,secondary AML, and refractory anemia with excess blasts in transformation[J]. Int-J-Hematol, 2000,71 (3) : 238-244.
  • 4Staib P, Lathan B, Knoppel-Sehwark S, et al. Cytosine arabinoside, etoposide and aclarubicin(AVA) for the treatment of acute myeloid leukemia(AML) in elderly patients[J]. Ann-Oncol, 1998,9(2) :221 - 223.
  • 5Steube KG, Gigaae SM, Hu ZB, et al. In vitro culture studies of childhood myelodysplastic syndrome: establishment of the cell line MUTZ- 1 [J].Leuk lymphoma 1997,25(3 - 4) :345 - 363.
  • 6Kern, W, Braess J, Grote Metke, et al. Combination of aclarubicin and etoposibe or the treatment of advanced acute myeloid leukemia: results of a prospective muiticenter phase Ⅱ trial.German AML. cooperative group[J].Leukemia, 1998,12(10) : 1522 - 1526.
  • 7Dartsch DC, Schaefer A, Boldt S, et al. Comparison of anthracycline-induced death of human leukemia cells : Programmed cell death versus necrosis[ J ]. Apoptosis. 2002,7 (6) : 537 - 548.

二级参考文献8

  • 1万景华,中华血液学杂志,1987年,8期,465页
  • 2赵敏顺,中国医学科学院学报,1985年,7期,89页
  • 3Jaffrézou JP,Levade T,Betta eb A,et al.Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis[].EMBO Journal.1996
  • 4Boland MP,Foster SJ,O’Neill LA.Daunorubicin activates NF-κB and inducesκB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cells[].Journal of Biological Chemistry.1997
  • 5Hannun YA.Apoptosis and the dilemma of cancer chemotherapy[].Blood.1997
  • 6Bose R,Verheij M,Haimovitz-Friedman A,et al.Ceramide synthase mediates daunorubicin-induced apoptosis[].Journal of Biological Chemistry.2000
  • 7Wang CY,Mayo MW,Baldwin AS Jr.TNF-and cancer therapy-induced apoptosis potentiation by inhibition of NF-кappa B[].Science.1996
  • 8Mansat-DeMas V,Bezombes C,Quillet-Mary A,et al.Implication of radicals oxygen species in ceramide generation, c-jun N-terminal kinase activation and induced by daunorubicin[].Molecular Pharmacology.1999

共引文献18

同被引文献9

  • 1程圭芳,丁敏,赵洁,何品刚,方禹之.抗癌药物阿克拉霉素A的氧化还原代谢机理研究[J].化学学报,2004,62(14):1299-1304. 被引量:5
  • 2沈莉菁,陈芳源,韩洁英,黄洪晖,钟华,钟璐,胡霄飞,欧阳仁荣.CAG方案治疗初治急性髓系白血病的疗效观察[J].临床血液学杂志,2004,17(6):355-357. 被引量:4
  • 3董凡 张桂如.抗白血病新药-阿克拉霉素A[J].中华血液学杂志,1988,9:180-180.
  • 4Bjorkholm M, Killander A. Datmombiein Versus aclarabiein in combina tion with cytarabine and thioguanine in elderly patierly patients with acute nonlym phocytic leukemia, a preliminary report[J]. Eur J Haematol, 1987,47(suppl):49.
  • 5De Nully Brown P, Hoffmann T, Hansen OP, et al. Long term survival and development of secondary malignancies in patients with acute myeloid leudemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase Ⅲtrial[J] .Leukemia,1997,11(1) :37.
  • 6Akashi K, Eto T, Shibuya T, et al. Aclarubicin induces differentiation of leukemic progenitors in myelodysplastic syndrome cooperating with granulocyte colony - stimulating factor [J]. Leuk Res, 2002,24:243 -248.
  • 7Dartsch DC, Schaefer A, Boldt S, et al. Comparison of anthracycline in duced death of human leudemia cells: Programmed cell death versus necrosis[J]. Apoptosis, 2002,7 (6):537 - 5481.
  • 8岑溪南,朱平,虞积仁,邱志祥,石永进,金山,马明信.急性粒细胞白血病化疗与体内细胞凋亡的关系[J].中华内科杂志,1997,36(5):300-303. 被引量:16
  • 9许洪志,徐健,邹俊晖,仲春红.小剂量化疗药物治疗急性白血病机制的研究[J].山西医药杂志,2002,31(2):102-104. 被引量:8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部